FYI From Human Genome Sciences: GlaxoSmithKline Study Shows GSK's Novel Diabetes Treatment Syncria(R) (Albiglutide) Improves Glucose Control, Reduces Weight
ROCKVILLE, Md. , June 8 /PRNewswire-FirstCall/ -- Attached is a press release issued yesterday by GlaxoSmithKline (GSK), regarding new Phase 2 data for Syncria(R) (albiglutide) presented at the American Diabetes Association 69th Scientific Sessions in New Orleans.
Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly redu...
Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
--Data from Phase 3 REDUCE-1 and REDUCE-2 Studies Demonstrate that Novel Combination Treatment Decreases Risk of Developing GI Ulcers by Approximately 50 Percent--
--Data presented today at 56th Annual Digestive Disease Week Meeting in Chicago--
CHICAGO, June 1 /PRNewswire/ -- Horizon T...
Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development
Data show superiority of endoscopic ablation therapy using the HALO System for eradicating Barrett's esophagus in randomized, multicenter, sham controlled trial
SUNNYVALE, Calif., May 27 /PRNewswire/ -- Results from a clinical study published today in the New England Journal of Medicine rev...
New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
PARSIPPANY, N.J., May 8 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that new data presented at the American Society of Hypertension, Inc. (ASH) Annual Scientific Meeting and Exposition (ASH 2009) in San Francisco from the BeniSILVER study found that BENICAR (R) and BENICAR HCT (R) pro...
Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
-Clinical Data Presented at American Pain Society Annual Meeting-
BALTIMORE, May 7 /PRNewswire/ -- Arcion Therapeutics, Inc., a venture backed clinical stage biotechnology company that develops pain therapies, today announced the presentation of data demonstrating that its lead candidate, ARC...
Adult Circumcision Reduces Risk of HIV Transmission Without Reducing Sexual Pleasure
LINTHICUM, Md., April 27 /PRNewswire-USNewswire/ -- Two studies presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA) show that adult circumcision reduces
the risk of contracting the human immunodeficiency virus (HIV) and the risk of coital injury -- without...
Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
QIAGEN donates one million tests to expand access to HPV screening in the world's poorest countries
VENLO, Netherlands, April 1 /PRNewswire-FirstCall/ -- Results from an eight-year trial involving more than 130,000 women published today in The New England Journal of Medicine (NEJM) demonst...
Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
- Adding Zometa to post-surgery hormone therapy reduced risk of breast cancer return or death by 36% more than hormone therapy alone
- First Phase III data to substantiate anticancer effect of Zometa
- Zometa is the most widely prescribed drug for prevention of bone complications due to ...
Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy
SEATTLE, Dec. 6 /PRNewswire-FirstCall/ -- Results from RESTORE 2, a
placebo-controlled, Phase III study demonstrated that the investigational
compound retigabine significantly reduced the number of seizures in adult
patients with refractory partial-onset epilepsy when a 600 mg or 900 mg dose
Healthy Bones Program Reduces Hip Fractures by 37 Percent, Kaiser Permanente Study Finds
Largest Study of Its Kind
PASADENA, Calif., Nov. 4 /PRNewswire/ -- Proactive measures can reduce
hip fracture rates by an average of 37.2 percent -- and as much as 50
percent -- among those at risk, according to a study conducted by Kaiser
Permanente Southern California....
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
More than 60 percent of moderate to severe patients achieved endoscopic
response and more than 40 percent achieved endoscopic remission at Week 10
in data from a 54-week open-label study presented at the American College
of Gastroenterology (ACG) Annual Scientific Meeting
ORLANDO, Fla., Oct....
Clinical Study Results: Nutrition 21's Iceland Health(R) Chromax(R) Chromium Picolinate Reduces Hunger, Food Intake and Cravings
Pennington Biomedical Research Center Studies 42 Overweight Women;
Chromax(R) cut hunger by 24%, food intake by 25%, and reduced high-fat food cravings
PURCHASE, N.Y., Sept. 23 /PRNewswire-FirstCall/ -- Nutrition 21, Inc.
(Nasdaq: NXXI ), the developer and ma...
Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis
Third Clinical Trial Reconfirms Strong Evidence Pycnogenol(R) Lowers Joint
Pain, Symptoms; May Now Have Lasting Effect on Joints Following Cessation of the Extract
HOBOKEN, N.J., Sept. 3 /PRNewswire/ -- According to the Center for
Disease Control (CDC), osteoarthrit...
National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
Northwestern Memorial Hospital one of 18 centers involved in 10-year study
CHICAGO, Aug. 27 /PRNewswire-USNewswire/ -- Results of a 10-year study
published in the August 28 issue of the New England Journal of Medicine
found that magnesium sulfate administered to women delivering before 32
New Study: Pine Bark Significantly Reduces Menstrual Pain
Multi-center Field Study Reveals Pycnogenol(R) Reduces
Need for Dysmenorrhea Pain Medication
HOBOKEN, N.J., June 18 /PRNewswire/ -- A new study reveals
dysmenorrhea, a condition that causes extremely painful menstrual periods
affecting millions of women each year, can ...
ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
- Phase III monotherapy study shows ACTEMRA is first and only biologic to
demonstrate statistical superiority over methotrexate after 24 weeks of treatment -
PARIS, June 13 /PRNewswire/ -- Patients who suffer the chronic and
debilitating effects of rheumatoid arth...
The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
SAN FRANCISCO, California, June 6 /PRNewswire/ --
- "ADVANCE Results go Beyond Existing Evidence"
New results from the world's largest ever study of diabetes treatments
show that intensive blood glucose (sugar) control using modified release
gliclazide and other drugs as required, protects...
Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
Blood pressure reductions demonstrated in Blacks, Hispanics/Latinos, People with Diabetes and Obese Individuals
PARSIPPANY, N.J., May 15 /PRNewswire/ -- Daiichi Sankyo, Inc.,
announced today that data presented at the American Society of
Hypertension's Twenty- Third Annual Scien...
Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
-No Metastatic Lesions Were Detectable After Combination Therapy Treatment- -Survival Time More Than Doubled in Animals Treated with Combination Therapy-
-Established Tumors Regressed by 50% After Combination Therapy Treatment-
SAN DIEGO and TUSTIN, Calif., April...
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
CHICAGO, April 1, 2008 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc.
(Nasdaq: CVTX ) today announced new data presented at the 57th Annual
Scientific Sessions of the American College of Cardiology shows that
Ranexa(R) (ranolazine extended release tablets) significantly reduced the
risk of r...
Recent Studies Suggest Popular 'Diet Pill' Relacore Reduces Acne Breakouts
NEW YORK, Feb. 15 /PRNewswire/ -- As crazy as it sounds, recent studies
conducted at Stanford and Wake Forest Schools of Medicine suggest there's a
connection between stubborn stress-related belly bulge, unsightly acne
flare- ups and the so-called "Belly Fat" pill, Relacore(R) (from the
Minimally Invasive Treatment Reduces Shoulder Pain From Tendonitis
CHICAGO, Nov. 28 /PRNewswire/ -- Radiologists are using a new minimally
invasive procedure to treat tendonitis in the shoulder. Ultrasound-guided
non-surgical therapy significantly reduces
pain from calcific tendonitis of
the rotator cuff and restores mobility, according to a study presented
Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows
BERKELEY, Calif., Nov. 20 /PRNewswire-USNewswire/ -- A new study
released by Indiana University researchers shows that strong smokefree
workplace laws result in immediate and significant improvements in heart
health, particularly in nonsmokers. The study found a 59% net decrease in
CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
Two Large Phase III Trials Confirm Robust Efficacy of CIMZIA
BOSTON, Nov. 7 /PRNewswire/ -- UCB announced today the results of new
Phase III data from the RAPID 1 and 2 studies presented at the American
College of Rheumatology Annual Scientific Meeting (ACR), which show
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
- Data confirms safety and HbA1c reductions seen in ischemic patients with diabetes in earlier clinical trials -
ORLANDO, Fla., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc.
(Nasdaq: CVTX ) announced today that data from a prospectively identified
analysis of 2,220 dia...
VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
SAN FRANCISCO and ORLANDO, Fla., Nov. 6 /PRNewswire-FirstCall/ -- VIA
Pharmaceuticals (Nasdaq: VIAP ), a biotechnology company focused on the
development of compounds for the treatment of cardiovascular disease, today
presented data showing that VIA-2291 significantly inhibited vascular
Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
Technology may improve quality of recovery compared with cold dissection procedure
SUNNYVALE, Calif., Nov. 6 /PRNewswire/ -- Starion Instruments, a
leading surgical device company, today announced that a study published in
the Annals of Otology, Rhinology & Laryng...
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Company Plans to File Supplemental New Drug Application with FDA in First Quarter 2008
SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Anesiva,
Inc. (Nasdaq: ANSV ) today announced positive top-line results from its
pivotal Phase 3 trial. The multi-c...
New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Lowest Dose of Estradiol Shown to Be Safe and Effective for Menopausal Women
WEST PALM BEACH, Fla., Oct. 3 /PRNewswire/ -- A study presented today
at the 2007 Annual Meeting of the North American Menopause Society (NAMS)
revealed that Divigel(R) (estradiol gel)...
Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Results Appear in the Sept. 12 Issue of the Journal of the American Medical Association
CLEVELAND, Sept. 11 /PRNewswire/ -- A drug widely used to treat type 2
diabetes has been found to reduce the risk of death, heart attack
(myocardial infarction) or stroke when use...
DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
- Need for Antibiotics Eliminated in 87 Percent of Patients, New Study Finds -
PRINCETON, N.J., Aug. 7 /PRNewswire/ -- DEFLUX(R) (non-animal
stabilized hyaluronic acid/dextranomer gel), for the treatment of
vesicoureteral reflux (VUR) in children, reduced the in...
Landmark Findings From ECLIPSE Program Show Improved Control of
Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
Largest Randomized Safety Program of Intravenous Antihypertensives
to Date Presented at ACC Scientific Sessions
NEW ORLEANS, March 27, 2007 /PRNewswire-FirstCall/ -- Findings
from ECLIPSE**, the largest safety program comparing intravenous
antihypertensive therapies, show that improved control of
Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus
Docetaxel Reduces Growth of Both Hormone-Dependent and
Hormone-Independent Prostate Cancer by Up to 94 Percent in
- Combination Therapy Significantly Decreased Tumor Blood Vessel
Density and Serum PSA Levels in Prostate Tumors -
LOS ANGELES and TUSTIN, Calif., April 17, 2007
/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a
clinical stage biopharmaceutical company developing targeted
New Data Show Xenical Significantly Reduces Cardiovascular Risk and
More Than Doubles Weight Loss Achieved in Overweight and Obese
BUDAPEST, April 24 /CNW/ - The weight loss medication Xenical
(orlistat 120mg) significantly reduces
weight and improves
cardiovascular risk factors such as blood pressure, glycaemic
control and lipid profile in overweight and obese people with type
2 diabetes and hypertension, according to a study...
AGI Dermatics Data Shows the 8 Oxo-Guanine Repair Enzyme OGG1
Encapsulated in Liposomes, Reduces MMP-1 and TNF-alpha in UV
Irradiated Skin Cells
Clinical Data Presented at the Society for Investigative
FREEPORT, N.Y., May 16, 2007 /PRNewswire-FirstCall/ -- AGI
Dermatics today announced new clinical research that the
8-oxo-guanine DNA glycosylase (OGG1) encapsulated in liposomes
enhances DNA repair and reduces
MMP-1 and TNF-alph...
Dynogen's DDP733 Reduces Reflux in Phase 1b GERD Study
- DDP733 reduces
esophageal reflux -
Waltham, Mass., June 7, 2007 – Dynogen Pharmaceuticals,
Inc. reported positive results of its randomized, double-blind,
placebo-controlled Phase 1b trial of DDP733 for gastroesophageal
reflux disease (GERD). The study was designed to demonstrate
Frova Phase III Study Data Demonstrates That Short-Term Prevention
Treatment Reduces Frequency and Severity of Menstrual Migraine
CHICAGO, IL, Jun 09, 2007 (MARKET WIRE via COMTEX News Network)
-- Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo
Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), has presented results
from a Phase III randomized, double-blind, placebo-controlled
clinical trial evaluating Frova (frovatr...
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
Eli Lilly and Company recently completed its Phase 1 study of LY2181308 and presented data confirming that LY2181308 penetrates tumor tissue and reduces
survivin mRNA and protein levels in tumor cells.
Isis and its collaborators highlighted new antisense therapeutic programs and t...
Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture
...d lipids during cleansing which is critical for optimal skin health. The formulation is comprised of sodium lauroyl isethionate, a mild cleanser that reduces
protein damage, and 100% skin-compatible natural moisturizers, including stearic acid, soybean oil and glycerin, that fully absorb into skin to replen...